Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC et al
Case Number:
1:22-cv-10185
Court:
Nature of Suit:
Judge:
Firms
- Ballard Spahr
- Cohen Milstein
- Greenberg Traurig
- Katten Muchin
- Keesal Young
- Morrison Foerster
- Paul Weiss
- Quinn Emanuel
Companies
Sectors & Industries:
-
February 15, 2024
Citadel Securities, Others Beat Biotech Spoofing Suit, For Now
A New York federal judge has adopted in full a magistrate judge's recommendation to toss a suit accusing several broker-dealers, including Citadel Securities LLC and Virtu Americas LLC, of carrying out a spoofing scheme that repeatedly drove a biotechnology company's share price down, saying he agrees with the report's finding that the suit fails to show that the alleged scheme caused lower stock prices in every instance.
-
March 21, 2023
Citadel Securities, Others Want Biotech Spoofing Suit Nixed
Several broker-dealers, including Citadel Securities LLC and Canaccord Genuity LLC, asked a New York federal judge on Monday to toss a suit accusing them of carrying out a spoofing scheme that repeatedly drove a biotechnology company's share price down, saying the case fails to allege any actionable trading or evidence of misconduct.
-
December 01, 2022
Biotech Co. Accuses Citadel Securities, Others Of Spoofing
Northwest Biotherapeutics Inc. on Thursday sued several broker-dealers including Citadel Securities LLC and Canaccord Genuity LLC in New York federal court for allegedly carrying out a spoofing scheme that repeatedly drove the biotechnology company's share price down despite promising developments with a cancer drug.